| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8226289 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 9 Pages |
Abstract
AR-42 is a potent, orally bioavailable inhibitor of HDAC with therapeutic value as a radiosensitizer of HCC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yen-Shen M.D., Ph.D., Chia-Hung Ph.D., Kai-Yuan M.D., Ming Ph.D., Ann-Lii M.D., Ph.D., Samuel K. Ph.D., Jason Chia-Hsien M.D., Ph.D.,